首页> 外文期刊>Journal of Bangladesh Society of Physiologist >Effect of omega-3 fatty acid supplementation on serum fasting glucose and HbA1c levels in type-2 Diabetes Mellitus
【24h】

Effect of omega-3 fatty acid supplementation on serum fasting glucose and HbA1c levels in type-2 Diabetes Mellitus

机译:补充ω-3脂肪酸对2型糖尿病患者血清空腹血糖和HbA1c水平的影响

获取原文
       

摘要

Background: Diabetes Mellitus (DM) is a major non-communicable health problem that have effects on glycemic status. Oral omega-3 fatty acid supplementation may improve glycemic status in diabetic patient.Objective: To observe the effect of supplementation of omega-3 fatty acid on fasting serum glucose (FSG) and glycosylated hemoglobin (HbA1c) levels in type 2 DM.Methods: This prospective interventional study was conducted from January 2017 to December 2017. A total numbers of 52 diagnosed type 2 diabetic patients(type-2 DM) of both sexes were selected with age 40 to 50 years. Among them, 27 type 2 diabetic patient with supplementation of omega 3 fatty acid (2g/day) for 12 weeks was considered as study group. Another 25 type 2 diabetic patients without supplementation of omega 3 fatty acid was considered as control group. The study subjects were selected from Outpatient Department of Endocrinology, Dhaka Medical College Hospital, Dhaka and personal contact from Dhaka city. FSG was estimated by enzymatic colorimetric method and HbA1c was estimated by turbidimetric inhibition immunoassay method. The study parameters were measured at base line and after 12 weeks of study period in both groups. For statistical analysis, Student’s paired ‘t’ test and Student’s unpaired ‘t’ test were performed as applicable using SPSS for windows version 16.0.Results: In this study serum FSG and HbA1c levels were significantly lower (p.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to that of their baseline value. Again, after 12 weeks, FSG and HbA1c levels significantly decreased (p.001) in omega-3 fatty acid supplemented diabetic patients compared to control group. In control group, there was no significant change in FSG and HbA1c levels between baseline and after 3 months of follow-up.Conclusion: From the results of the study, it can be concluded that omega-3 fatty acid may improve serum FSG and HbA1c levels in type 2 diabetic patient and may be helpful to minimize the complications of type-2 DM.
机译:背景:糖尿病(DM)是一个主要的非传染性健康问题,对血糖状况有影响。目的:口服omega-3脂肪酸可改善糖尿病患者的血糖状况。目的:观察omega-3脂肪酸对2型糖尿病患者空腹血糖(FSG)和糖化血红蛋白(HbA1c)水平的影响。这项前瞻性干预研究于2017年1月至2017年12月进行。选择了40位年龄在40至50岁之间的52位经诊断的2型糖尿病患者(2型糖尿病)。其中,以27名2型糖尿病患者补充12周的欧米加3脂肪酸(2g /天)作为研究组。另外25例2型糖尿病患者,不补充欧米加3脂肪酸作为对照组。研究对象选自达卡市达卡医学院附属医院内分泌科门诊和达卡市的个人联系人。用酶比色法估算FSG,用比浊抑制免疫分析法估算HbA1c。两组均在基线和研究期12周后测量研究参数。为了进行统计分析,使用适用于Windows 16.0版的SPSS进行了学生配对t检验和学生非配对t检验。结果:在本研究中,糖尿病患者的血清FSG和HbA1c水平显着降低(p <0.001)补充omega-3脂肪酸与其基线值相比。同样,在12周后,与对照组相比,补充omega-3脂肪酸的糖尿病患者的FSG和HbA1c水平显着降低(p <0.001)。对照组在基线和随访3个月后FSG和HbA1c水平无明显变化。结论:从研究结果可以得出结论,ω-3脂肪酸可以改善血清FSG和HbA1c降低2型糖尿病患者的血脂水平,可能有助于减少2型糖尿病的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号